Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64:73–84

PubMed  Google Scholar 

Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, Yang JD, Tan E, Muthiah MD (2023) Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol 29:S32–S42

PubMed  Google Scholar 

Vilar-Gomez E, Calzadilla-Bertot L, Wong VW-S, Castellanos M, la Fuente RA, Metwally M, Eslam M, Gonzalez-Fabian L, Sanz MA-Q, Conde-Martin AF, Boer BD, McLeod D, Chan AWH, Chalasani N, George J, Adams LA, Romero-Gomez M (2018) Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology 155:443-457.e17

PubMed  Google Scholar 

Zhu Y, Hu H, Wu Y, Rao Y, Li Q, Duan X, Yao G, Yin H, Luo Z (2023) The association between fatty liver index and onset of diabetes: secondary analysis of a population-based cohort study. BMC Public Health 23:679

CAS  PubMed  PubMed Central  Google Scholar 

Park J, Kim G, Kim H, Lee J, Jin S-M, Kim JH (2022) The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study. Cardiovasc Diabetol 21:287

CAS  PubMed  PubMed Central  Google Scholar 

Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, Kleiner DE, Loomba R (2023) AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77:1797–1835

PubMed  Google Scholar 

Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ (2009) Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 51:1061–1067

PubMed  PubMed Central  Google Scholar 

Cohen EB, Afdhal NH (2010) Ultrasound-based hepatic elastography: origins, limitations, and applications. J Clin Gastroenterol 44:637

PubMed  Google Scholar 

Pickhardt PJ, Graffy PM, Reeder SB, Hernando D, Li K (2018) Quantification of liver fat content with unenhanced MDCT: phantom and clinical correlation with MRI proton density fat fraction. AJR Am J Roentgenol 211:W151–W157

PubMed  PubMed Central  Google Scholar 

Bohte AE, van Werven JR, Bipat S, Stoker J (2011) The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 21:87–97

PubMed  Google Scholar 

Ghahremani GG, Hahn ME, Fishman EK (2023) Computed tomography of hyper-attenuated liver: pictorial essay. Clin Imaging 97:1–6

PubMed  Google Scholar 

Fazel R, Krumholz HM, Wang Y, Ross JS, Chen J, Ting HH, Shah ND, Nasir K, Einstein AJ, Nallamothu BK (2009) Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 361:849–857

CAS  PubMed  PubMed Central  Google Scholar 

Kramer H, Pickhardt PJ, Kliewer MA, Hernando D, Chen G-H, Zagzebski JA, Reeder SB (2017) Accuracy of liver fat quantification with advanced CT, MRI, and ultrasound techniques: prospective comparison with MR spectroscopy. AJR Am J Roentgenol 208:92–100

PubMed  Google Scholar 

Gu J, Liu S, Du S, Zhang Q, Xiao J, Dong Q, Xin Y (2019) Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Eur Radiol 29:3564–3573

PubMed  Google Scholar 

Iacobellis G (2005) Imaging of visceral adipose tissue: an emerging diagnostic tool and therapeutic target. Curr Drug Targets Cardiovasc Haematol Disord 5:345–353

CAS  PubMed  Google Scholar 

Neeland IJ, Ross R, Després J-P, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin B, Zambon A, Barter P, Fruchart J-C, Eckel RH, International Atherosclerosis Society, International Chair on Cardiometabolic Risk Working Group on Visceral Obesity (2019) Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol 7:715–725

PubMed  Google Scholar 

Hanlon CL, Yuan L (2022) Nonalcoholic fatty liver disease: the role of visceral adipose tissue. Clin Liver Dis (Hoboken) 19:106–110

PubMed  Google Scholar 

Loomba R, Abdelmalek MF, Armstrong MJ, Jara M, Kjær MS, Krarup N, Lawitz E, Ratziu V, Sanyal AJ, Schattenberg JM, Newsome PN, NN9931-4492 Investigators (2023) Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial. Lancet Gastroenterol Hepatol 8:511–522

CAS  PubMed  PubMed Central  Google Scholar 

Flint A, Andersen G, Hockings P, Johansson L, Morsing A, Sundby Palle M, Vogl T, Loomba R, Plum-Mörschel L (2021) Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging. Aliment Pharmacol Ther 54:1150–1161

CAS  PubMed  PubMed Central  Google Scholar 

Kuchay MS, Krishan S, Mishra SK, Choudhary NS, Singh MK, Wasir JS, Kaur P, Gill HK, Bano T, Farooqui KJ, Mithal A (2020) Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial). Diabetologia 63:2434–2445

CAS  PubMed  Google Scholar 

Tejani S, McCoy C, Ayers CR, Powell-Wiley TM, Després J-P, Linge J, Leinhard OD, Petersson M, Borga M, Neeland IJ (2022) Cardiometabolic health outcomes associated with discordant visceral and liver fat phenotypes: insights from the Dallas heart study and UK biobank. Mayo Clin Proc 97:225–237

PubMed  Google Scholar 

Kang GH, Cruite I, Shiehmorteza M, Wolfson T, Gamst AC, Hamilton G, Bydder M, Middleton MS, Sirlin CB (2011) Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging 34:928–934

PubMed  PubMed Central  Google Scholar 

Mashhood A, Railkar R, Yokoo T, Levin Y, Clark L, Fox-Bosetti S, Middleton MS, Riek J, Kauh E, Dardzinski BJ, Williams D, Sirlin C, Shire NJ (2013) Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging. J Magn Reson Imaging 37:1359–1370

PubMed  Google Scholar 

Serai SD, Dillman JR, Trout AT (2017) Proton density fat fraction measurements at 1.5- and 3-T hepatic MR imaging: same-day agreement among readers and across two imager manufacturers. Radiology 284:244–254

PubMed  Google Scholar 

Kim HJ, Cho HJ, Kim B, You M-W, Lee JH, Huh J, Kim JK (2019) Accuracy and precision of proton density fat fraction measurement across field strengths and scan intervals: a phantom and human study. J Magn Reson Imaging 50:305–314

PubMed  Google Scholar 

Arnold TC, Freeman CW, Litt B, Stein JM (2023) Low-field MRI: clinical promise and challenges. J Magn Reson Imaging 57:25–44

PubMed  Google Scholar 

Campbell-Washburn AE, Ramasawmy R, Restivo MC, Bhattacharya I, Basar B, Herzka DA, Hansen MS, Rogers T, Bandettini WP, McGuirt DR, Mancini C, Grodzki D, Schneider R, Majeed W, Bhat H, Xue H, Moss J, Malayeri AA, Jones EC, Koretsky AP, Kellman P, Chen MY, Lederman RJ, Balaban RS (2019) Opportunities in interventional and diagnostic imaging by using high-performance low-field-strength MRI. Radiology 293:384–393

PubMed  Google Scholar 

Marques JP, Simonis FFJ, Webb AG (2019) Low-field MRI: an MR physics perspective. J Magn Reson Imaging 49:1528–1542

PubMed  PubMed Central  Google Scholar 

Wald LL, McDaniel PC, Witzel T, Stockmann JP, Cooley CZ (2020) Low-cost and portable MRI. J Magn Reson Imaging 52:686–696

PubMed  Google Scholar 

Campbell-Washburn AE, Mancini C, Conrey A, Edwards L, Shanbhag S, Wood J, Xue H, Kellman P, Bandettini WP, Thein SL (2022) Evaluation of hepatic iron overload using a contemporary 0.55 T MRI system. J Magn Reson Imaging 55:1855–1863

PubMed  Google Scholar 

Chandarana H, Bagga B, Huang C, Dane B, Petrocelli R, Bruno M, Keerthivasan M, Grodzki D, Block KT, Stoffel D, Sodickson DK (2021) Diagnostic abdominal MR imaging on a prototype low-field 0.55 T scanner operating at two different gradient strengths. Abdom Radiol (NY) 46:5772–5780

PubMed  Google Scholar 

Nayak KS, Cui SX, Tasdelen B, Yagiz E, Weston S, Zhong X, Ahlgren A (2023) Body composition profiling at 0.55T: feasibility and precision. Magn Reson Med 90:1114–1120

CAS  PubMed  Google Scholar 

Ramachandran A, Hussain HK, Gulani V, Kelsey L, Mendiratta-Lala M, Richardson J, Masotti M, Dudek N, Morehouse J, Panagis KR, Wright K, Seiberlich N (2024) Abdominal MRI on a commercial 0.55T system: initial evaluation and comparison to higher field strengths. Acad Radiol 31:3177–3190

PubMed  Google Scholar 

Tasdelen B, Lee NG, Cui SX, Nayak KS (2024) Improved abdominal T1 weighted imaging at 0.55T. Magn Reson Med. https://doi.org/10.1002/mrm.30224 Epub 2024 Jul 12. PMID: 38997798

PubMed  PubMed Central  Google Scholar 

Shih S-F, Tasdelen B, Yagiz E, Zhang Z, Zhong X, Cui SX, Nayak KS, Wu HH (2025) Improved liver fat and R 2 * quantification at 0.55 T using locally low-rank denoising. Magn Reson Med 93:1348–1364

CAS  PubMed  Google Scholar 

Kanwal F, Neuschwander-Tetri BA, Loomba R, Rinella ME (2024) Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American association for the study of liver diseases practice guidance on nonalcoholic fatty liver disease. Hepatology 79:1212–1219

PubMed  Google Scholar 

Zhong X, Nickel MD, Kannengiesser SAR, Dale BM, Kiefer B, Bashir MR (2014) Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging. Magn Reson Med 72:1353–1365

PubMed  Google Scholar 

Hu HH, Yokoo T, Bashir MR, Sirlin CB, Hernando D, Malyarenko D, Chenevert TL, Smith MA, Serai SD, Middleton MS, Henderson WC, Hamilton G, Shaffer J, Shu Y, Tkach JA, Trout AT, Obuchowski N, Brittain JH, Jackson EF, Reeder SB, Committee for the RQIBAPB (2021) Linearity and bias of proton density fat fraction as a quantitative imaging biomarker: a multicenter, multiplatform, multivendor phantom study. Radiology. https://doi.org/10.1148/radiol.2021202912